Effectiveness and safety of tenofovir amibufenamide and tenofovir alafenamide in treating elderly patients diagnosed with decompensated hepatitis B cirrhosis: a retrospective cohort study
TMF treatment in elderly patients with decompensated hepatitis B cirrhosis had a good antiviral effect, no adverse drug reaction on renal function and blood lipids, and high safety. TMF is not inferior to TAF in antiviral efficacy and safety.
Authors
- Yue Yin (ORCID: https://orcid.org/0000-0002-9434-7827)
- Xinye Qiu (ORCID: https://orcid.org/0000-0002-9760-5932)
- Wei Liu (ORCID: https://orcid.org/0000-0001-8430-0497)
- Shibin Zhang (ORCID: https://orcid.org/0000-0001-9928-256X)
Institutions
- Capital Medical University (CN)
- Peking University (CN)
- Peking University Cancer Hospital (CN)
- Beijing YouAn Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.3389/fphar.2025.1545108
- Citations
- 4
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.42